Antidepressant augmentation: good news, limitations, and stumbling blocks
- PMID: 25919849
- DOI: 10.4088/JCP.14com09536
Antidepressant augmentation: good news, limitations, and stumbling blocks
Abstract
Dr Zhou and colleagues have done an excellent job of reviewing and analyzing the world's literature on the efficacy and tolerability of pharmacologic agents used to augment antidepressants in treatment-resistant unipolar major depression. It seems we have some good news, but a lot remains to be accomplished. The good news is that several agents were found to have significant efficacy in terms of response (4 agents) and remission (6 agents) in comparison to placebo.
© Copyright 2015 Physicians Postgraduate Press, Inc.
Comment on
-
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.J Clin Psychiatry. 2015 Apr;76(4):e487-98. doi: 10.4088/JCP.14r09204. J Clin Psychiatry. 2015. PMID: 25919841
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
